In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Schering-Plough licenses rights to Sepracor patents

Executive Summary

Schering-Plough licensed exclusive rights to patents owned by Sepracor (chiral drugs) covering descarboethoxyloratainde (DCL), an active metabolite of SP's loratadine, the active ingredient in its successful antihistamine Claritin.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Chiral Chemistry
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies